EYEN
Eyenovia, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website eyenovia.com
- Employees(FY) 41
- ISIN US30234E1047
Performance
-6.8%
1W
+35.51%
1M
-55.89%
3M
-41.87%
6M
-63.95%
YTD
-78.99%
1Y
Profile
Eyenovia, Inc., a pre-commercial ophthalmic company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. It focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi in rest of Asia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.
Technical Analysis of EYEN 2024-05-10
Overview:
In analyzing the technical indicators for EYEN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions to guide your invest...
Recent News & Updates
- 2024-05-15 15:07
- 2024-05-15 08:55
- 2024-05-15 04:01
- 2024-05-13 19:00
- 2024-05-09 18:31
- 2024-04-24 19:00
- 2024-04-08 21:29
- 2024-04-07 19:00
- 2024-04-02 19:00
- 2024-03-26 23:28
- 2024-03-26 21:57
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call(Yahoo Finance)
- 2024-03-18 20:50
- 2024-03-18 18:41
Q4 2023 Eyenovia Inc Earnings Call(Yahoo Finance)
- 2024-03-18 08:53
- 2024-03-18 05:20
- 2024-03-18 04:05
- 2024-03-12 19:00
- 2024-03-10 19:00
- 2024-03-04 23:59
- 2024-03-04 19:00
- 2024-03-04 05:21
- 2024-03-04 05:06
US FDA approves Eyenovia's eye drug, Formosa Pharma says(Yahoo Finance)
- 2024-02-12 18:00
- 2024-01-25 20:22
- 2024-01-15 18:00
- 2023-12-14 19:17
- 2023-11-13 21:38
- 2023-11-13 03:05
- 2023-11-05 19:00
- 2023-11-01 19:00
Page 1 of 5
previousnext